1.Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase

Wan, EYF, Wang, BY,     More...

Wan, EYF, Wang, BY, Mathur, S, Chan, CIY, Yan, VKC, Lai, FTT, Chui, CSL, Li, X, Wong, CKH, Li, PH, Lau, CS, Wong, ICK, Chan, EWY     Less

JOURNAL OF INFECTION[0163-4453], Published 2023, Volume 86, Issue 6, Pages 622-625

收錄情况： WOS SCOPUS

WOS核心合集引用: 7  2023影響因子:  14.3  发表年影響因子:  14.3 

2.Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)

Li, X, Peng, K, Chen     More...

Li, X, Peng, K, Cheng, FWT, Lam, DCL, Cheung, CL, Chui, CSL, Lai, FTT, Wan, EYF, Wong, CKH, Ma, TT, Yum, SHH, Chan, EWY, Huang, JD, Lau, CS, Ip, MSM, Wong, ICK     Less

JOURNAL OF INFECTION[0163-4453], Published 2023, Volume 86, Issue 3, Pages 299-302

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2023影響因子:  14.3  发表年影響因子:  14.3 

3.Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study

Wan, EYF, Mok, AHY,     More...

Wan, EYF, Mok, AHY, Yan, VKC, Wang, BY, Zhang, R, Hong, SN, Chui, CSL, Li, X, Wong, CKH, Lai, FTT, Tan, KCB, Lau, CS, Wong, ICK, Chan, EWY     Less

JOURNAL OF INFECTION[0163-4453], Published 2022, Volume 85, Issue 5, Pages E140-E144

收錄情况： WOS SCOPUS

WOS核心合集引用: 23  2023影響因子:  14.3  发表年影響因子:  28.2